Vical Incorporated (VICL) Reports First Quarter 2013 Financial Results and Progress in Key Development Programs
5/9/2013 10:04:42 AM
More...
|
Vical Incorporated (VICL) to Present at May Investor Conferences
5/7/2013 9:36:28 AM
More...
|
Vical Incorporated (VICL) Release: Vaxfectin® Enhances Preclinical Immune Responses to Baxter's Cell Culture-Derived Influenza Vaccines
5/6/2013 9:42:44 AM
More...
|
Vical Incorporated (VICL) Announces Publication of Herpes Simplex Vaccine Guinea Pig Study Data
2/4/2013 9:05:19 AM
More...
|
Vical Incorporated (VICL) Announces News Release and Conference Call Schedule for 2012 Financial Results
1/30/2013 9:28:35 AM
More...
|
Vical Incorporated (VICL) to Present at 31st Annual J.P. Morgan Healthcare Conference
1/3/2013 9:05:51 AM
More...
|
Vical Incorporated (VICL) Named to NASDAQ Global Select Market
1/2/2013 9:11:57 AM
More...
|
Vical Incorporated (VICL) to Present at Credit Suisse 2012 Healthcare Conference
11/12/2012 7:48:40 AM
More...
|
Vical Incorporated (VICL) Release: Preclinical Data Support Potential Combinations for Allovectin® With Emerging Immunotherapies
11/8/2012 9:24:06 AM
More...
|
Vical Incorporated (VICL) Reports Third Quarter 2012 Financial Results and Progress in Key Development Programs
11/7/2012 9:15:23 AM
More...
|
|